Vistra (VST) Options Chain & Prices $140.44 -2.18 (-1.53%) As of 12:48 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VST Put and Call Options List 1/21/2028 12/17/2027 9/17/2027 3/19/2027 1/15/2027 12/18/2026 10/16/2026 9/18/2026 8/21/2026 7/17/2026 6/26/2026 6/18/2026 6/12/2026 6/5/2026 5/29/2026 5/22/2026 5/15/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades5/15/2026$115.00$0.014Put32 - 1536(+6)110.33% (+9.93%)-0.00408535/15/2026$120.00$0.031Put2295647916(+46)98.80% (+7.20%)-0.0090141165/15/2026$125.00$0.071Put1053866465(-29)87.52% (+4.50%)-0.020944655/15/2026$125.00$17.554Call2 - - 12(-1)87.52% (+4.50%)0.97947125/15/2026$126.00$0.084Put20 - 10(+0)85.29% (+3.96%)-0.024963205/15/2026$126.00$16.568Call2 - - 3(+1)85.29% (+3.96%)0.97545325/15/2026$127.00$15.585Call2111(+1)83.09% (+3.43%)0.97059325/15/2026$128.00$0.120Put1 - - 56(+2)80.90% (+2.91%)-0.03571815/15/2026$129.00$0.145Put29 - 1150(-3)78.73% (+2.39%)-0.042882215/15/2026$130.00$0.175Put1164405934(-16)76.58% (+1.88%)-0.05159653 Get the Latest News and Ratings for VST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vistra and its competitors with MarketBeat's FREE daily newsletter. 5/15/2026$130.00$12.661Call1 - 169(-1)76.58% (+1.88%)0.9488415/15/2026$131.00$0.212Put3020 - 8(+0)74.46% (+1.39%)-0.06222425/15/2026$132.00$0.258Put1511414(+5)72.38% (+0.91%)-0.075183105/15/2026$133.00$0.316Put15448(+2)70.35% (+0.46%)-0.090989105/15/2026$134.00$0.388Put85233(+9)68.36% (+0.04%)-0.11025655/15/2026$135.00$0.477Put488783622473(+2)66.44% (-0.34%)-0.133658565/15/2026$136.00$0.590Put7055377(+43)64.60% (-0.67%)-0.161948125/15/2026$136.00$7.078Call2525 - 0(+0)64.60% (-0.67%)0.83875625/15/2026$137.00$0.732Put1898139(+59)62.86% (-0.94%)-0.19591495/15/2026$137.00$6.220Call4220(+0)62.86% (-0.94%)0.80495135/15/2026$138.00$0.910Put653116200(+19)61.25% (-1.12%)-0.236235305/15/2026$139.00$1.133Put583214123(+4)59.79% (-1.20%)-0.283353265/15/2026$140.00$1.410Put404631742374(+19)58.51% (-1.15%)-0.3372681325/15/2026$140.00$3.897Call701337143(-1)58.51% (-1.15%)0.664627375/15/2026$141.00$1.750Put5148 - 127(+46)57.45% (-0.95%)-0.39732585/15/2026$141.00$3.236Call1,2316355861(+0)57.45% (-0.95%)0.605157595/15/2026$142.00$2.162Put921451333(+51)56.64% (-0.58%)-0.462049355/15/2026$142.00$2.645Call251127510(+0)56.64% (-0.58%)0.541155675/15/2026$143.00$2.651Put40 - 26289(+40)56.10% (-0.02%)-0.529169105/15/2026$143.00$2.132Call6725172(+2)56.10% (-0.02%)0.474864295/15/2026$144.00$3.220Put35105382(+18)55.84% (+0.71%)-0.59589315/15/2026$144.00$1.697Call4272515(+0)55.84% (+0.71%)0.409012315/15/2026$145.00$3.865Put278168202191(+46)55.88% (+1.62%)-0.659403785/15/2026$145.00$1.337Call22910781332(+12)55.88% (+1.62%)0.346326755/15/2026$146.00$4.580Put2686108(+29)56.18% (+2.66%)-0.71744995/15/2026$146.00$1.048Call113177445(+3)56.18% (+2.66%)0.289026305/15/2026$147.00$5.357Put353 - 231(+6)56.73% (+3.80%)-0.768553135/15/2026$147.00$0.818Call3521498(-37)56.73% (+3.80%)0.238499165/15/2026$148.00$6.184Put36145143(-1)57.49% (+5.00%)-0.8121865/15/2026$148.00$0.639Call27717773171(+34)57.49% (+5.00%)0.19525649Microscopic Footage Shows Immune Cells Attacking Cancer (Ad)Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using its TriKE platform, which is designed to keep Natural Killer cells active and targeted longer than standard approaches. The company's next-generation version shows potential for 10-40x greater potency and has already cleared an important FDA milestone. Watch the microscopic footage and see what the next catalyst could mean for investors.Watch the footage and learn about the company's next catalyst5/15/2026$149.00$7.051Put151 - 121(+0)58.43% (+6.21%)-0.84854455/15/2026$149.00$0.501Call7557779(+6)58.43% (+6.21%)0.159097135/15/2026$150.00$7.950Put5111853136(-7)59.52% (+7.40%)-0.878477615/15/2026$150.00$0.394Call37092131904(-35)59.52% (+7.40%)0.129364705/15/2026$152.50$10.292Put16 - 1343(-3)62.69% (+10.16%)-0.930548105/15/2026$152.50$0.222Call1442557592(+60)62.69% (+10.16%)0.077393455/15/2026$155.00$12.712Put41731406(-21)66.25% (+16.96%)-0.960623215/15/2026$155.00$0.131Call418101801041(+74)66.25% (+12.47%)0.0472171105/15/2026$157.50$15.173Put511332(-49)70.00% (+14.37%)-0.97765255/15/2026$157.50$0.080Call17612182156(+66)70.00% (+14.37%)0.029606425/15/2026$160.00$17.652Put35951678(-34)73.83% (+15.95%)-0.987315225/15/2026$160.00$0.051Call7712004293120(+155)73.83% (+15.95%)0.0191111715/15/2026$162.50$20.142Put24 - - 72(+21)77.65% (+17.30%)-0.99276965/15/2026$162.50$0.034Call53 - 41964(-12)77.65% (+17.30%)0.012686145/15/2026$165.00$22.636Put73 - 48454(-142)81.45% (+18.49%)-0.995857325/15/2026$165.00$0.023Call10111273169(-267)81.45% (+18.49%)0.008641245/15/2026$167.50$25.133Put2 - - 16(-16)85.20% (+19.56%)-0.99761225/15/2026$167.50$0.016Call161 - 296(+9)85.20% (+19.56%)0.0060257End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Constellation Energy Options Data EMCOR Group Options Data NRG Energy Options Data National Grid Transco Options Data Enterprise Products Partners Options Data American Electric Power Options Data TC Energy Options Data Energy Transfer Options Data Xcel Energy Options Data Exelon Options Data Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:VST) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic Footage Shows Immune Cells Attacking CancerEarly human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...Market Tactic | SponsoredYou're not getting into the SpaceX IPO. Do this instead.The SpaceX IPO is expected to price at $1.75 trillion - and retail investors won't get an allocation. Banks an...Behind the Markets | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredThe Rare Earth Shift Few Saw ComingRare earth elements are the hidden backbone of electric vehicles, modern defense technology, and advanced elec...i2i Marketing Group, LLC | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vistra Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vistra With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VST Stock Alerts